Shkreli Atty Rips Retrophin Over Katten Doc Privilege Row

By Stewart Bishop (November 22, 2016, 8:11 PM EST) -- An attorney for former Turing Pharmaceuticals Inc. CEO Martin Shkreli on Tuesday told a Brooklyn federal judge that drugmaker Retrophin Inc. is preventing a swath of documents held by his former lawyers at Katten Muchin Rosenman LLP from coming into Shkreli's criminal case in order to save itself millions of dollars owed to its former CEO....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!